CLINICAL_TRIALS
trial_result
· 2017-11-07
Clinical Trial Update: An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480) [Phase 3]
Summary
An extension Phase 3 trial of duloxetine in osteoarthritis of the knee completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2017-11-07